GlassScriptPhysician profile
Gregory P Siroky
NPI 1225447956
$62,446.06
in general payments reported to CMS, 2019-2025
19 companies · $1,562 in 2025
The $1,562 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $2,448 · 2021: $25K · 2022: $4,864 · 2023: $3,874 · 2024: $3,925 · 2025: $1,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,697 · Travel and Lodging: $1,664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,696.83 |
| Travel and Lodging | $1,664.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $19,077.06 | 2019-2025 | Emblem Mri S-Icd, Watchman Flx, Watchman Access System |
| Medtronic Vascular, INC. | $16,921.78 | 2019 | |
| Abbott Laboratories | $11,495.72 | 2019-2025 | Aveir, Gallant, Jot Dx |
| Medtronic, INC. | $8,280.61 | 2021-2025 | Mycarelink, Selectsecure, Linq II |
| Biosense Webster, INC. | $2,339.35 | 2021-2025 | Carto 3, Qdot Micro Catheter, Qdot Micro |
| Biotronik INC. | $2,227.51 | 2021-2025 | Acticor 7 Vr-T Dx, Selectra |
| Philips North America LLC | $800.31 | 2023-2025 | (Am5) Lead Management, Mechanical Tools |
| Kestra Medical Technology Services, INC. | $373.91 | 2022-2024 | Assure Wcd |
| Medical Device Business Services, INC. | $241.19 | 2024 | Carto 3 |
| Atricure, INC. | $176.37 | 2023 | |
| Stereotaxis INC | $112.76 | 2021 | |
| Cardiva Medical, INC. | $89.95 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $70.78 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $69.32 | 2022-2024 | Bridion |
| Baylis Medical Company INC | $47.45 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $37.74 | 2023 | Cleviprex, Kengreal |
| Cumberland Pharmaceuticals, INC. | $37.74 | 2022-2023 | Caldolor |
| Melinta Therapeutics, LLC | $25.31 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Siroky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.